Evaluating a New Marker’s Predictive Contribution
暂无分享,去创建一个
[1] R. Simon. Evaluating Prognostic Factor Studies , 2003 .
[2] F. Harrell,et al. Evaluating the yield of medical tests. , 1982, JAMA.
[3] W. Sauerbrei,et al. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. , 1994, Journal of the National Cancer Institute.
[4] Michael W Kattan,et al. Judging new markers by their ability to improve predictive accuracy. , 2003, Journal of the National Cancer Institute.
[5] D. G. Altman,et al. Statistical aspects of prognostic factor studies in oncology. , 1994, British Journal of Cancer.
[6] Brian O'Sullivan,et al. Prognostic factors in cancer. , 2003 .
[7] Sunil J Rao,et al. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .
[8] R. Bast,et al. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. , 1996, Journal of the National Cancer Institute.
[9] Douglas G. Altman,et al. Methodological challenges in the evaluation of prognostic factors in breast cancer , 2004, Breast Cancer Research and Treatment.
[10] Daniel F. Hayes,et al. Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful? , 2004, Breast Cancer Research and Treatment.
[11] C. Chatfield. Model uncertainty, data mining and statistical inference , 1995 .